Cargando…

Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases

BACKGROUND: Pemphigoids are rare diseases associated with IgG, IgE and IgA autoantibodies against collagen XVII/BP180. An entity of the pemphigoid group is the lamina lucida-type of linear IgA disease (IgA pemphigoid) characterized by IgA autoantibodies against BP180. While for the detection of IgG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Csorba, Kinga, Schmidt, Sabine, Florea, Florina, Ishii, Norito, Hashimoto, Takashi, Hertl, Michael, Kárpáti, Sarolta, Bruckner-Tuderman, Leena, Nishie, Wataru, Sitaru, Cassian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126693/ https://www.ncbi.nlm.nih.gov/pubmed/21619684 http://dx.doi.org/10.1186/1750-1172-6-31

Ejemplares similares

Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid
por: Nagarajan, Harish, et al.
Publicado: (2023)

The Flavonoid Luteolin Inhibits Fcγ-Dependent Respiratory Burst in Granulocytes, but Not Skin Blistering in a New Model of Pemphigoid in Adult Mice
por: Oswald, Eva, et al.
Publicado: (2012)

Evaluation of the Role of BIOCHIP Mosaic Based Indirect Immunofluorescence and ELISA BP 180 and BP 230 Autoantibodies in the Diagnosis of Bullous Pemphigoid Patients
por: Nithya, VPS, et al.
Publicado: (2022)

Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180
por: Mai, Yosuke, et al.
Publicado: (2019)

BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid
por: Liu, Yale, et al.
Publicado: (2017)

Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients
por: Chiorean, Roxana M., et al.
Publicado: (2018)

Association of Autoantibodies to BP180 with Disease Activity in Greek Patients with Bullous Pemphigoid
por: Patsatsi, Aikaterini, et al.
Publicado: (2012)

Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases
por: Licarete, Emilia, et al.
Publicado: (2012)

Blister-inducing antibodies target multiple epitopes on collagen VII in mice
por: Csorba, Kinga, et al.
Publicado: (2014)

High Index Values of Enzyme-Linked Immunosorbent Assay for BP180 at Baseline Predict Relapse in Patients With Bullous Pemphigoid
por: Koga, Hiroshi, et al.
Publicado: (2018)

Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study
por: Sernicola, Alvise, et al.
Publicado: (2019)

Diagnostic values of indirect immunofluorescence using salt-split skin, direct immunofluorescence and BP180 NC16A ELISA on bullous pemphigoid
por: Li, Suo, et al.
Publicado: (2022)

Analysis of the autoimmune response against BP180 and BP230 in ethnic Poles with neurodegenerative disorders and bullous pemphigoid
por: Gornowicz-Porowska, Justyna, et al.
Publicado: (2017)

Anti-BP180 Autoantibodies Are Present in Stroke and Recognize Human Cutaneous BP180 and BP180-NC16A
por: Wang, Yanan, et al.
Publicado: (2019)

A Cross-Sectional Study to Correlate Disease Severity in Bullous Pemphigoid Patients with Serum Levels of Autoantibodies Against BP180 and BP230
por: Muhammed, Naziya, et al.
Publicado: (2021)

Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrin
Publicado: (1995)

Native Autoantigen Complex Detects Pemphigoid Autoantibodies
por: Mai, Shoko, et al.
Publicado: (2023)

The Localization of Bullous Pemphigoid Antigen 180 (BP180) in Hemidesmosomes Is Mediated by Its Cytoplasmic Domain and Seems to be Regulated by the β4 Integrin Subunit
por: Borradori, Luca, et al.
Publicado: (1997)

Case report: Detection of anti-bullous pemphigoid antigen 180 antibodies in a patient with Behçet’s disease
por: Didona, Dario, et al.
Publicado: (2022)

Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BP180 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous Pemphigoid
por: Lee, Eui Hyung, et al.
Publicado: (2012)

The significance of preclinical anti-BP180 autoantibodies
por: Mai, Yosuke, et al.
Publicado: (2022)

Bullous pemphigoid in infants: characteristics, diagnosis and treatment
por: Schwieger-Briel, Agnes, et al.
Publicado: (2014)

Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients
por: Gasparini, Giulia, et al.
Publicado: (2023)

Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders
por: Didona, Dario, et al.
Publicado: (2021)

Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid
por: Cole, Connor, et al.
Publicado: (2022)

Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid
por: Chiorean, Roxana, et al.
Publicado: (2018)

Use of gliptins reduces levels of SDF-1/CXCL12 in bullous pemphigoid and type 2 diabetes, but does not increase autoantibodies against BP180 in diabetic patients
por: Nätynki, Antti, et al.
Publicado: (2022)

Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance
por: Tukaj, Stefan, et al.
Publicado: (2022)

Newer Treatment Modalities in Epidermolysis Bullosa
por: Bruckner-Tuderman, Leena
Publicado: (2019)

Skin Fragility: Perspectives on Evidence-based Therapies
por: BRUCKNER-TUDERMAN, Leena
Publicado: (2020)

Radiation-Associated Pemphigus Vulgaris in a Patient With Preceding Malignancy: Treatment With Rituximab as a Valuable Option
por: Schauer, Franziska, et al.
Publicado: (2020)

The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases
por: Sitaru, Cassian, et al.
Publicado: (2007)

BP180/Collagen XVII: A Molecular View
por: Tuusa, Jussi, et al.
Publicado: (2021)

The Epidermolysis bullosa Center Freiburg – patient care, diagnostics and research
por: Bruckner-Tuderman, Leena, et al.
Publicado: (2014)

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid
por: Tasanen, Kaisa, et al.
Publicado: (2019)

Anti-FcαRI Monoclonal Antibodies Resolve IgA Autoantibody-Mediated Disease
por: Bos, Amelie, et al.
Publicado: (2022)

Analysis of the autoimmune response to BP180 in Chinese stroke patients()
por: Wang, Jing, et al.
Publicado: (2023)

Immunopathology and molecular diagnosis of autoimmune bullous diseases
por: Mihai, Sidonia, et al.
Publicado: (2007)

Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody
por: Clapé, Ariane, et al.
Publicado: (2018)

Mapping health care of rare diseases: the example of epidermolysis bullosa in Germany
por: Reimer, Antonia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7je7uorkgp8o20o53kcv8aqco7